P
Peter G. Gibson
Researcher at University of Newcastle
Publications - 774
Citations - 53254
Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
Alterations in inflammatory, antiviral and regulatory cytokine responses in peripheral blood mononuclear cells from pregnant women with asthma.
Rebecca L. Vanders,Peter G. Gibson,Peter G. Gibson,Peter A. B. Wark,Peter A. B. Wark,Vanessa E. Murphy +5 more
TL;DR: A balance between antiviral and inflammatory immune responses is critical during pregnancy; the balance may be altered by asthma and respiratory virus infection.
Journal ArticleDOI
Comparison of sputum processing techniques in cystic fibrosis
TL;DR: It is concluded that published sputum processing methods for asthma using DTT give false results when applied to CFSputum, which should be processed using an enzyme mixture.
Journal ArticleDOI
Development of Bronchial Hyperreactivity Following Transient Absence of Salivary IgA
Maree Gleeson,R L Clancy,Michael J. Hensley,A W Cripps,Richard L. Henry,John Wlodarczyk,Peter G. Gibson +6 more
TL;DR: The inconsistency in the relationships between the transient absence of salivary IgA and atopy, asthma, and BHR supports the concept that atopic, wheeze, and bronchial hyperreactivity are independent clinical outcomes.
Journal ArticleDOI
Neutrophilic asthma: welcome back!
TL;DR: Bullone and co-workers show that neutrophilic asthma is a subtype in which the IL-17 pathway seems to be operational and can be recognised by quantitative immunostaining of bronchial biopsy specimens and may be amenable to specific targeted therapies.
Journal ArticleDOI
Ciclesonide versus placebo for chronic asthma in adults and children
TL;DR: Ciclesonide was more effective than placebo, in the short term, in improving lung function in patients with mild to moderate asthma previously treated with inhaled corticosteroids.